Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -6.51% is 66% above its 5-year average of -19.08%, near the high end of its 5-year range (-48.28%–-3.04%).
58.85% above its 12-month average of -15.82%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 0.90%.
RETURN ON ASSETS (ROA)
-6.51%
RETURN ON ASSETS (ROA) AVG TTM
-15.82%
RETURN ON ASSETS (ROA) AVG 3Y
-25.09%
RETURN ON ASSETS (ROA) AVG 5Y
-19.08%
RETURN ON ASSETS (ROA) AVG 10Y
-7.91%
RETURN ON ASSETS (ROA) AVG 15Y
2.38%
RETURN ON ASSETS (ROA) AVG 20Y
3.56%
CURRENT VS TTM AVG
+58.85%
CURRENT VS 3Y AVG
+74.06%
CURRENT VS 5Y AVG
+65.88%
CURRENT VS 10Y AVG
+17.75%
CURRENT VS 15Y AVG
-373.68%
CURRENT VS 20Y AVG
-282.92%
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+79.82%
vs the sector median at left
KORU Medical Systems, Inc.
Market Cap
$137.80M
Return on Assets (ROA)
-6.51%
TTM Avg
-15.82%
3Y Avg
-25.09%
5Y Avg
-19.08%
Market Cap
$136.67M
Return on Assets (ROA)
-33.22%
TTM Avg
-27.55%
3Y Avg
-27.55%
5Y Avg
-27.55%
Market Cap
$136.57M
Return on Assets (ROA)
10.55%
TTM Avg
-7.15%
3Y Avg
-30.40%
5Y Avg
-23.45%
Market Cap
$139.04M
Return on Assets (ROA)
-28.35%
TTM Avg
-69.97%
3Y Avg
-58.34%
5Y Avg
-49.63%
Market Cap
$139.47M
Return on Assets (ROA)
-36.33%
TTM Avg
-27.39%
3Y Avg
-256.74%
5Y Avg
-207.88%
Market Cap
$139.84M
Return on Assets (ROA)
-92.89%
TTM Avg
-84.34%
3Y Avg
-55.16%
5Y Avg
-43.29%
Market Cap
$143.10M
Return on Assets (ROA)
-59.36%
TTM Avg
-56.73%
3Y Avg
-42.41%
5Y Avg
-32.43%
Market Cap
$132.03M
Return on Assets (ROA)
-35.50%
TTM Avg
-18.07%
3Y Avg
-62.20%
5Y Avg
-134.72%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | $137.80M | -6.51% | -15.82% | -25.09% | -19.08% |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.67M | -33.22% | -27.55% | -27.55% | -27.55% |
| Organigram Global Inc. (OGI)vs › | $136.57M | 10.55% | -7.15% | -30.40% | -23.45% |
| Immuneering Corporation (IMRX)vs › | $139.04M | -28.35% | -69.97% | -58.34% | -49.63% |
| Alpha Cognition Inc (ACOG)vs › | $139.47M | -36.33% | -27.39% | -256.74% | -207.88% |
| Sutro Biopharma, Inc. (STRO)vs › | $139.84M | -92.89% | -84.34% | -55.16% | -43.29% |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.10M | -59.36% | -56.73% | -42.41% | -32.43% |
| LifeMD, Inc. (LFMD)vs › | $132.03M | -35.50% | -18.07% | -62.20% | -134.72% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | -39.76% | -26.00% | -40.35% | -34.25% |
ROA
-6.5%
ROE
-10.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -9.35% |
| 2024-12-31 | -22.29% |
| 2023-12-31 | -48.28% |
| 2022-12-31 | -20.46% |
| 2021-12-31 | -11.05% |
| 2020-12-31 | -3.04% |
| 2019-12-31 | 4.07% |
| 2018-12-31 | 8.64% |
| 2017-12-31 | 11.70% |
| 2017-02-28 | -6.55% |
| 2016-02-29 | 9.55% |
| 2015-02-28 | 10.34% |
| 2014-02-28 | 11.33% |
| 2013-02-28 | 12.98% |
| 2012-02-29 | 16.98% |
| 2011-02-28 | 22.83% |
| 2010-02-28 | 37.21% |
| 2009-02-28 | 44.62% |
| 2008-02-29 | -0.21% |
| 2007-02-28 | -22.37% |
| 2006-02-28 | -23.75% |
| 2005-02-28 | -39.58% |
| 2004-02-29 | -23.40% |
| 2003-02-28 | -24.15% |
| 2002-02-28 | -27.59% |
| 2001-02-28 | -7.24% |
| 2000-02-29 | 15.90% |
